Hyperprolactinaemia
- PMID: 29375184
- PMCID: PMC5768604
- DOI: 10.18773/austprescr.2017.060
Hyperprolactinaemia
Keywords: dopamine agonist; hyperprolactinaemia; prolactin; prolactinoma.
Conflict of interest statement
Conflict of interest: Morton Burt was previously awarded a competitive Pfizer cardiovascular lipid research grant.
Figures
References
-
- McKenna TJ. Should macroprolactin be measured in all hyperprolactinaemic sera? Clin Endocrinol (Oxf) 2009;71:466-9. Available from: https://doi.org/10.1111/j.1365-2265.2009.03577.x 10.1111/j.1365-2265.2009.03577.x - DOI - DOI - PubMed
-
- Ciccarelli A, Daly AF, Beckers A. The epidemiology of prolactinomas. Pituitary 2005;8:3-6. Available from: https://doi.org/10.1007/s11102-005-5079-0 10.1007/s11102-005-5079-0 - DOI - DOI - PubMed
-
- Karavitaki N, Thanabalasingham G, Shore HC, Trifanescu R, Ansorge O, Meston N, et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf) 2006;65:524-9. Available from: https://doi.org/10.1111/j.1365-2265.2006.02627.x 10.1111/j.1365-2265.2006.02627.x - DOI - DOI - PubMed
-
- Molitch ME. Medication-induced hyperprolactinemia. Mayo Clin Proc 2005;80:1050-7. Available from: https://doi.org/10.4065/80.8.1050 10.4065/80.8.1050 - DOI - DOI - PubMed
-
- Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:273-88. Available from: https://doi.org/10.1210/jc.2010-1692 10.1210/jc.2010-1692 - DOI - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources